1. Home
  2. GCTK vs SMX Comparison

GCTK vs SMX Comparison

Compare GCTK & SMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • SMX
  • Stock Information
  • Founded
  • GCTK 2001
  • SMX N/A
  • Country
  • GCTK United States
  • SMX Ireland
  • Employees
  • GCTK N/A
  • SMX N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • SMX Industrial Machinery/Components
  • Sector
  • GCTK Health Care
  • SMX Technology
  • Exchange
  • GCTK Nasdaq
  • SMX Nasdaq
  • Market Cap
  • GCTK 5.1M
  • SMX 4.8M
  • IPO Year
  • GCTK N/A
  • SMX N/A
  • Fundamental
  • Price
  • GCTK $0.37
  • SMX $2.96
  • Analyst Decision
  • GCTK
  • SMX
  • Analyst Count
  • GCTK 0
  • SMX 0
  • Target Price
  • GCTK N/A
  • SMX N/A
  • AVG Volume (30 Days)
  • GCTK 4.1M
  • SMX 571.1K
  • Earning Date
  • GCTK 03-27-2025
  • SMX 12-27-2024
  • Dividend Yield
  • GCTK N/A
  • SMX N/A
  • EPS Growth
  • GCTK N/A
  • SMX N/A
  • EPS
  • GCTK N/A
  • SMX N/A
  • Revenue
  • GCTK N/A
  • SMX N/A
  • Revenue This Year
  • GCTK N/A
  • SMX N/A
  • Revenue Next Year
  • GCTK N/A
  • SMX N/A
  • P/E Ratio
  • GCTK N/A
  • SMX $2.11
  • Revenue Growth
  • GCTK N/A
  • SMX N/A
  • 52 Week Low
  • GCTK $0.36
  • SMX $2.85
  • 52 Week High
  • GCTK $99.00
  • SMX $835.71
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 26.08
  • SMX 38.18
  • Support Level
  • GCTK $0.49
  • SMX $2.96
  • Resistance Level
  • GCTK $0.68
  • SMX $3.65
  • Average True Range (ATR)
  • GCTK 0.20
  • SMX 0.45
  • MACD
  • GCTK 0.17
  • SMX 0.26
  • Stochastic Oscillator
  • GCTK 0.71
  • SMX 9.47

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

Share on Social Networks: